Capital International, Inc. Ab Cellera Biologics Inc. Transaction History

Capital International, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.46 - $14.14 $6.93 Million - $13.1 Million	-929,578 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$12.99 - $17.73 $280,272 - $382,542	-21,576 Reduced 2.27%	929,578 $13.3 Million
Q3 2021 Nov 15, 2021	SELL	$14.85 - $21.34 $200,311 - $287,855	-13,489 Reduced 1.4%	951,154 $19.1 Million
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $19.5 Million - $33 Million	964,643 New	964,643 $21.2 Million

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $833M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

Stay updated on Capital International, Inc. with notifications on news.